Skip to search formSkip to main contentSkip to account menu

sulmazole

Known as: 1H-Imidazo(4,5-b)pyridine, 2-(2-methoxy-4-(methylsulfinyl)phenyl)-, 2-((2-methoxy-4-methylsulfinyl)phenyl)-H-imidazo(4,5-b)pyridine, sulmazol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1997
Review
1997
Lysosomotropic agents are selectively taken up into lysosomes following their administration to man and animals [de Duve et al… 
1994
1994
1 The effect of sulmazole and several structurally related analogues on cardiac sarcoplasmic reticulum (SR) Ca2+‐release channel… 
Highly Cited
1991
Highly Cited
1991
1. The gating and conduction properties of single calcium‐release channels of sheep isolated cardiac junctional sarcoplasmic… 
Highly Cited
1988
Highly Cited
1988
Although many of the new cardiotonic agents are known to increase cAMP and to inhibit with variable potency a low Km cAMP… 
Highly Cited
1986
Highly Cited
1986
Intracellular Ca++ transients were monitored in preparations of mammalian heart muscle in which multiple superficial cells had… 
Highly Cited
1986
Highly Cited
1986
In isolated canine ventricular trabeculae and papillary muscles driven electrically at 0.5 Hz at 37 degrees C, the positive… 
1985
1985
MDL 17,043 [1,3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one] and AR-L 115 BS [sulmazole, 2-[(2-methoxy-4… 
Review
1984
Review
1984
  • H. Scholz
  • Journal of the American College of Cardiology
  • 1984
  • Corpus ID: 28832571
1983
1983
We compared the hemodynamic and metabolic effects of dobutamine and sulmazol (AR-L115 BS) in normal dogs and in dogs with chronic…